Talk:James W. Black
From Wikipedia, the free encyclopedia
 |
This article is within the scope of WikiProject Biography. For more information, visit the project page. | ||
| ??? | This article has not yet received a rating on the Project's quality scale. Please rate the article and then leave a short summary here to explain the ratings and/or to identify the strengths and weaknesses of the article. [FAQ] | ||
 |
It is requested that a photograph or photographs be included in this article to improve its quality. |
[edit] Cimetidine
There needs to be an entry on his work with the SmithKline&French H2-receptor antagonist programm that produced cimetidine (tagamet) which made ulcers managable, earned SK&F billions, allowed them to expand hugely into research, and probably cemented the Nobel Prize for him. I don't think propanolol alone would have done that. Rather it was one of the first successful pursuits of rational drug design. Someone in the know might add the interesting story about how SK&F failed to patent the equivalent ranitidine. A link to Hâ‚‚-receptor antagonist might also be appropriate.--Beanmf 15:19, 10 February 2007 (UTC)
[edit] Alumnus of Dundee?
James W Black graduated (Medicine) from the University of St Andrews in 1946. What was to become University of Dundee was called "University College" at that time, Queen's College of St Andrews University operated between 1954 and 1967. By this stage in his career, he was working with ICI Pharma and Smith, Kline & French. → friedfish 13:05, 7 November 2006 (UTC)
